AI Analysis

How does BAFNAPH.NS make money? Does BAFNAPH.NS have pricing power? What's the Earnings Whisper? Will BAFNAPH.NS profit more as the business scales? What is BAFNAPH.NS's management track record? Is BAFNAPH.NS's current price justified?

Bafna Pharmaceuticals Limited

₹461.35 +$312.96 (+210.90%)

NSE · 16 Oct 2026 09:44 UTC

Previous Close

₹452.35

Day Range

₹460₹461.35

Year Range

₹94.77₹461.35

Market Cap

10.91B

AVG Volume

18.28K

Trailing/Forward PE

140.23/-

PEG ratio

-24.47

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

BAFNAPH.NS Revenue (INR) by year
Period	Revenue (INR)
2026	1.51B
2025	1.46B
2024	1.52B
2023	1.15B
2022	851.4M
2021	712.18M
2020	424.73M
2019	549.06M

Net Income (INR) · A

BAFNAPH.NS Net Income (INR) by year
Period	Net Income (INR)
2026	111M
2025	41.52M
2024	73.48M
2023	113.38M
2022	51.51M
2021	58.27M
2020	-254.21M
2019	-176.37M

Operating Income (INR) · A

BAFNAPH.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	98.75M
2025	62.87M
2024	61.16M
2023	115.6M
2022	64.35M
2021	61.38M
2020	-19.61M
2019	-40.23M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Bafna Pharmaceuticals Limited

Video analysis: BAFNAPH.NS

News: BAFNAPH.NS

Similar companies